Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400516 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Victória C Tietz und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Síntese e Química Medicinal (LASQUIM)., Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição, Universidade Federal de Mato Grosso…. Hauptthemen laut MEDLINE: Drug Design, Triazoles, Sulfonamides, Trypanosoma cruzi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001, CNPq, FUNDECT N° 31/2021 - Universal 2021 - ODS.
Abstract (Originalsprache)
A series of 2‐nitroimidazole‐1,2,3‐triazole sulfonamide hybrid analogs were designed using medicinal chemistry approaches, such as bioisosterism, molecular hybridization, Topliss tree decision, and Craig plot. A total of 24 compounds were synthesized via click chemistry in satisfactory yields. Overall, analogs 15 a‐x exhibited relevant in vitro anti‐trypanosomatid activity against amastigote forms of T. cruzi and without cytotoxic effect on LLC–MK2 cells. Analogs 15 b (R 1 =4‐Cl−Ph; IC 50 =1.63 μM, SI=>30.65), 15 m (R 1 =3,4‐ di ‐Cl−Ph; IC 50 =0.63 μM, SI=>78.96), and 15 s (R 1 =Ph‐4‐O−Ph; IC 50 =0.63 μM, SI=>79.90) demonstrated pronounced antitrypanosomal activity, more active than the reference drug, benznidazole and with good selectivity indexes. Furthermore, analog 15 b (R 1 =4‐Cl−Ph; IC 50 =0.5 μM, SI=>100) exhibited an outstanding antileishmanial activity against amastigote forms of Leishmania (L.) amazonensis and impressive selectivity index, comparable to the reference compound amphotericin B. The mutagenicity of compounds 15 b and 15 m were evaluated against Salmonella typhimurium strains (TA98, TA100 and TA102). Compound 15 b exhibited mutageniticy only at a concentration of 500 μg/plate for the TA100 strain, whereas compound 15 m was considered non‐mutagenic. These findings suggest that 2‐nitroimidazoles‐1,2,3‐triazole sulfonamide hybrid analogs are promising anti‐trypanosomatid candidates for future in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Síntese e Química Medicinal (LASQUIM)., Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição, Universidade Federal de Mato Grosso do Sul (UFMS), Avenida Costa e Silva, s/n, Bairro Universitário, Camp…
- Laboratório de Parasitologia Humana, Instituto de Biociências, Universidade Federal de Mato Grossso do Sul (UFMS), Avenida Costa e Silva, s/n, Bairro Universitário, Campo Grande, Mato Grosso do Sul, CEP 79070-900, Brazi…
- Laboratório de Parasitologia, Departamento de Análises Clínicas Toxicológicas e Bromatológicas, Universidade de São Paulo (USP), Avenida do Café, s/n, Monte Alegre, Ribeirão Preto, São Paulo, CEP 14040-903, Brazil.
- Faculdade de Ciências Biológicas e Ambientais, Universidade Federal da Grande Dourados (UFGD), Rodovia Dourados-Itahum, Km 12, Cidade Universitária, Dourados, Mato Grosso do Sul, CEP 79804-970, Brazil.
- Departamento de Química e Biologia (DABQI), Universidade Tecnológica Federal de Paraná (UTFPR), Rua Deputado Heitor Alencar Furtado, 4900, Cidade Industrial, Curitiba, Paraná, CEP 81280-340, Brazil.
- Departamento de Química, Universidade Federal do Paraná (UFPR), CP 19081, Curitiba, Paraná, CEP 81531-990, Brazil.
ORCID-Profile: Cleison R Leite, Fabiana G S Dantas, Kelly M P Oliveira, Adriano C M Baroni
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001, CNPq
- FUNDECT N° 31/2021 - Universal 2021 - ODS
Zitieren
APA
Tietz, V. C., Ortale, M. L. F., das Neves, A. R., Pelizaro, B. I., Carvalho, D. B., Shiguemoto, C. Y. K., Portapilla, G. B., Silva, T. S., Silva, F., Piranda, E. M., Leite, C. R., Dantas, F. G. S., Oliveira, K. M. P., Guerrero, P. G., Marques, F. A., LaGatta, D. C., Arruda, C. C. P., de Albuquerque, S., & Baroni, A. C. M. (2025). Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents. ChemMedChem. https://doi.org/10.1002/cmdc.202400516
Vancouver
Tietz VC, Ortale MLF, das Neves AR, Pelizaro BI, Carvalho DB, Shiguemoto CYK, et al. Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents. ChemMedChem. 2025. doi:10.1002/cmdc.202400516
BibTeX
@article{Tietz2025,
author = {Tietz, Victória C and Ortale, Maria L F and das Neves, Amarith R and Pelizaro, Bruno I and Carvalho, Diego B and Shiguemoto, Cristiane Y K and Portapilla, Gisele B and Silva, Talicia S and Silva, Fernanda and Piranda, Eliane M and Leite, Cleison R and Dantas, Fabiana G S and Oliveira, Kelly M P and Guerrero, Palimecio G and Marques, Francisco A and LaGatta, Davi C and Arruda, Carla C P and de Albuquerque, Sergio and Baroni, Adriano C M},
title = {Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400516}
}
EUVIMED